查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1837188

輔助人工心臟市場（按流量等級、設備類型、適應症、產品類型和最終用戶分類）—2025-2032 年全球預測

Ventricular Assist Device Market by Flow Class, Device Type, Indication, Product, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年輔助人工心臟市場將成長至 34.1 億美元，複合年成長率為 6.48%。

主要市場統計數據
基準年2024年 20.6億美元
預計2025年 21.9億美元
預測年份：2032年 34.1億美元
複合年成長率（%） 6.48%

從臨床、技術和醫療系統角度看輔助人工心臟的現狀

過去十年，輔助人工心臟為晚期心臟衰竭治療途徑中不可或缺的選擇。現代輔助人工心臟的結構著重於降低血栓形成風險、結構緊密和能量效率，這些因素的結合使其在老年患者和併發症患者中的應用範圍不斷擴大。同時，先進的手術方法和經經皮聯合策略降低了手術全期風險，使其在三級醫療機構和專科中心廣泛應用。

此外，臨床模式的轉變正在模糊臨時和長期機械循環支持之間的傳統界限，促使臨床醫生考慮在某些患者群體的疾病發展早期採用器械治療。付款人和醫療保健系統越來越注重基於價值的治療結果和降低再入院率，這提升了器械的長期性能和全面的植入護理計劃的重要性。因此，製造商、臨床醫生和醫院正在共同努力，收集證據和真實世界數據，以量化改善生活品質和長期生存的益處。

同時，法律規範也不斷發展，以促進器械的迭代改進，在保障病人安全的同時，兼顧病患的及時取得和強力的上市後監管。這些動態共同構成了一個複雜而又肥沃的環境，為整個輔助人工心臟輔助治療生態系統的創新、夥伴關係和策略差異化發展提供了機會。

確定將重塑機械循環支持臨床實踐、技術開發和商業模式的轉型轉變

一些趨同的變化正在發生，這些變化正在重新定義輔助人工心臟的開發、評估和部署方式。首先，包括軸向和離心平台在內的連續流設計方面的工程進步正在提高血流動力學效率和耐用性，從而影響手術選擇和長期管理。其次，數位遙測和遠端監控功能的整合使得主動管理設備性能和患者狀態成為可能，從而縮短了門診醫生和植入團隊之間的回饋迴路。

同時，臨床證據正在將適應症從傳統的「過渡到移植」模式擴展到「過渡到復原」模式以及針對特定族群的最終治療，這促使多學科團隊重新評估適應症標準。以患者為中心的治療結果的興起，正在將衡量標準從生存率轉向功能狀態和生活品質，從而影響報銷討論和臨床應用。此外，隨著企業追求垂直整合、製造擴充性和跨轄區監管協調，以加快迭代設備更新的上市時間，製造和供應鏈策略也不斷發展。

最後，醫療設備製造商、學術中心和衛生系統之間的策略合作正在加速轉化研究和真實世界證據的產生。此類夥伴關係有助於促進適應性臨床試驗設計和註冊，從而更好地了解器械的長期性能和併發症，從而為患者選擇、手術全期通訊協定和植入後護理的迭代改進提供資訊。

檢驗近期和預期的美國關稅政策變化對輔助人工心臟價值鍊和籌資策略的累積影響

2025年實施的關稅調整增加了整個輔助人工心臟供應鏈的複雜性，影響零件、成品系統和輔助耗材。這些政策變化加強了醫院採購團隊和設備製造商的採購審查力度，促使他們重新檢視籌資策略、供應商多元化和製造外包管理。為此，一些製造商已與合約製造商合作，以加快關鍵零件的本地生產，並降低貿易相關價格波動帶來的風險。

醫療保健提供者已採取相應措施，加強採購管治，並尋求簽訂長期供應協議，以確保價格穩定和醫療服務的連續性。同時，規模較小的供應商和利基零件供應商正在尋求擴大規模，以消化關稅相關的成本壓力，從而可能促成整合。重要的是，臨床團隊正在密切監測設備供應和服務部件的間接影響，因為即使是輕微的中斷也可能影響計畫中的植入項目和植入後支援。

政策不確定性也增強了總成本分析在採購決策中的作用，醫院系統尋求提高土地購買成本、保固條款和服務網路可靠性方面的透明度。因此，積極調整商業模式，提供配套服務協議、更優的前置作業時間保證和本地化支援的製造商，將在調整後的資費環境中保持競爭優勢。

解釋流程架構、設備類型、臨床指徵、產品組合和護理環境的細分動態，以發現策略機會和臨床交叉點

連續流系統和脈動平台之間流動結構的區別持續影響臨床實踐。連續流裝置，尤其是軸向和離心式裝置，因其可靠性和小巧外形而備受青睞，而脈動技術則在臨床上更傾向於生理性脈動的領域中佔據著獨特的地位。左心室輔助、右心室輔助和雙心室輔助裝置類型的分類清楚地展現了治療意圖如何決定技術設計。雖然左心室輔助是最常用的慢性支持方法，但右心室輔助和雙心室輔助在急性缺血和複雜的手術全期病例中也發揮著重要作用。

基於適應症（例如復健過渡期、移植過渡期和最終照護）的差異化不僅影響臨床決策，還會影響醫療保健系統內的方案設計。在產品層面，選擇外部設備或植入式設備，也與患者的生活方式、感染風險管理以及長期設備維護策略相互關聯。最後，終端使用者細分（包括門診手術中心和醫院）凸顯了醫療服務模式的演變。

這些細分軸的交集產生了細微的採用模式和服務需求，這表明，如果製造商和供應商能夠將其產品開發、臨床支援和培訓計劃與這些差異化需求相結合，那麼他們將能夠更好地滿足臨床醫生的偏好和患者的期望。

法律規範、付款人動態和臨床應用的地區差異影響著全球的商業化和證據生成策略

美洲地區擁有先進的三級醫療網路、集中的植入專家隊伍，以及強調強力的臨床證據和上市後監測的監管路徑，這些條件有利於先進植入技術的採用和綜合護理方案的落地。相較之下，歐洲、中東和非洲地區情況複雜，報銷機制、國家衛生部門流程和醫院採購模式差異巨大，因此需要靈活的商業化策略和針對特定區域的臨床參與。同時，在亞太地區，一些市場正在快速發展醫療保健基礎設施，而另一些市場則擁有高度發展的卓越中心，同時注重成本效益解決方案和尖端創新技術的採用。

在全部區域，當地的臨床實踐模式、外科醫生的經驗以及心臟衰竭專科計畫的密度都會影響新設備架構融入治療流程的速度。此外，各地區在協調監管和加強上市後資料收集方面的努力正在減少跨司法管轄區的證據生成障礙，但實施時間仍然不均衡。因此，尋求全球擴張的公司必須調整其臨床教育、服務網路和報​​銷策略，以滿足不同的付款人期望和醫療保健服務模式，同時利用區域卓越中心來推動臨床醫生的採用並建立可靠的真實世界證據。

整個設備生態系統的競爭動態和夥伴關係策略，重點是平台創新、服務整合和證據主導的差異化

一些公司優先改進設備，以提高血液相容性或電池效率，而其他公司則強調整合遠端監控和預測分析的平台計劃。設備開發商與學術機構之間的策略夥伴關係加速了轉化研究和臨床檢驗，從而縮短了迭代改進週期。此外，垂直整合的服務網路和不斷壯大的內部技術支援團隊已成為尋求與醫院建立長期合作關係並確保植入設備高正常運轉率的公司的關鍵差異化因素。

併購仍然是取得互補技術、增強服務能力和擴大地域覆蓋範圍的重要途徑，尤其對於那些尋求填補產品線空白或增強上市後監測基礎設施的公司而言。同時，新參與企業和專業零件供應商正憑藉傳動系統感染緩解、感測器整合和血液動力學最佳化演算法等領域的利基創新，挑戰現有企業。這些競爭動態共同作用，不僅優先考慮設備性能，還優先考慮臨床培訓的品質、保固和服務承諾的清晰度，以及支持長期患者療效的證據深度。

為了加強設備治療的供應彈性、證據產生和價值主導的商業模式，製造商和醫療保健提供者應採取以下策略重點：

首先，我們將優先投資於上市後資料收集和遠端監控基礎設施，以驗證設備在現實世界中的效能，並推動早期臨床應用。將證據產生工作與付款人需求和臨床醫生的優先事項相結合，將有助於促進報銷討論，並支持更廣泛的應用。其次，我們將透過多元化關鍵零件供應商，並盡可能探索本地製造夥伴關係，增強供應鏈韌性，以減少貿易相關中斷和前置作業時間波動帶來的風險。第三，我們將開發捆綁式產品，將設備硬體、保固範圍和可預測的服務合約結合在一起，以簡化採購流程並降低醫院系統的營運風險。

此外，擴大臨床醫生教育項目，將模擬、監考和跨學科護理團隊培訓納入其中，以最大程度地減少手術全期併發症並最佳化患者選擇。利用區域卓越中心促進P2P知識轉移，並產生高品質的真實世界證據。最後，採用以病人為中心的產品開發概念，強調生活品質、易用性和長期照護協作。透過協調一致地實施這些建議，領導者可以增強競爭優勢，同時改善臨床結果和營運可靠性。

透過整合主要臨床訪談、次要證據綜合和相關人員檢驗的嚴格混合方法研究途徑獲得可靠的見解

本研究整合了定性和定量方法，旨在提供關於臨床實踐、技術趨勢和商業性動態的全面視角。主要資料收集包括對臨床醫生、臨床工程師、採購主管和監管專家的結構化訪談，以了解現場對設備性能、服務期望和採用障礙的觀點。二次文獻整合則利用了同行評審的臨床研究、指南聲明、監管文件和技術白皮書，以將主要研究結果與臨床聲明聯繫起來並檢驗。

此外，我們也透過結構化的相關人員檢驗會議來協調分歧、檢驗分析得出的假設並完善建議。必要時，我們會交叉引用器械技術規格、台架試驗報告和上市後監測摘要，以支持關於器械構造和臨床應用的主張。我們透過對資訊來源應用透明的納入標準、記錄訪談通訊協定以及採用迭代三角測量法來提高可靠性，從而保持了調查方法的嚴謹性。這種混合方法設計確保了見解以臨床為基礎，並與決策者的操作相關。

將技術進步、不斷發展的臨床實踐和持續推進機械循環支援的策略要求結合起來的簡明綜合

綜上所述，輔助人工心臟領域正處於曲折點，工程技術的進步、臨床適應症的演變以及商業性現實的變遷，共同創造了新的機會和挑戰。設備在流量技術、小型化和數位化整合方面的改進，正在擴大患者可及性和更精細的護理路徑，而與關稅相關的供應鏈壓力以及監管和報銷的地區差異，則要求企業製定適應性的商業和營運策略。因此，成功的組織將是那些將卓越的技術與強大的證據生成、彈性供應網路以及全面的臨床醫生和患者支持計劃相結合的組織。

展望未來，製造商、臨床負責人和醫療系統之間需要協調一致，優先收集真實世界數據，簡化採購模式，並加強培訓，這對於將技術潛力轉化為持續的臨床效益至關重要。透過讓相關人員專注於這些綜合優先事項，我們可以改善患者預後，降低系統層面的風險，並將器械治療定位為晚期心臟衰竭治療模式中持久的、以患者為中心的選擇。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 配備無線經皮能量傳輸系統的完全植入式左心室輔助裝置的採用率日益提高
  • 整合機器學習演算法對輔助人工心臟併發症進行預測監測和早期預警
  • 磁浮幫浦技術的發展可減少 VAD 患者的溶血和裝置相關血栓症
  • 目的地治療適應症的擴大正在推動對長期輔助人工心臟支持的需求
  • 臨床試驗評估生物相容性表面塗層以最大程度降低 VAD植入的免疫反應和感染風險
  • 微型兒科連續流泵的設計促進了輔助人工心臟計畫的發展
  • 監管核准和報銷政策塑造下一代植入式輔助設備的可及性
  • 新興的遠端患者監護平台，用於植入式心室輔助裝置的即時數據傳輸

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章輔助人工心臟市場流程分類

  • 常規流量
    • 軸流
    • 離心流
  • 脈動流

第9章輔助人工心臟市場（依設備類型）

  • 兩個房間
  • 左邊
  • 正確的

第10章輔助人工心臟市場（依適應症）

  • 通往復甦的橋樑
  • 移植橋樑
  • 目的地療法

第 11 章。輔助人工心臟市場（按產品）

  • 外部的
  • 嵌入式

第 12 章輔助人工心臟市場（依最終使用者）

  • 門診手術中心
  • 醫院

第13章輔助人工心臟市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章輔助人工心臟市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。輔助人工心臟市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • Medtronic plc
    • Abiomed, Inc.
    • LivaNova PLC
    • Berlin Heart GmbH
    • Jarvik Heart, Inc.
    • CARMAT SA
    • CorWave SAS
    • Terumo Corporation
    • SynCardia Systems, LLC
Product Code: MRR-034B5003038B

The Ventricular Assist Device Market is projected to grow by USD 3.41 billion at a CAGR of 6.48% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.06 billion
Estimated Year [2025] USD 2.19 billion
Forecast Year [2032] USD 3.41 billion
CAGR (%) 6.48%

Framing the contemporary ventricular assist device landscape with clinical, technological, and health-system context

Over the past decade, ventricular assist devices have transitioned from niche salvage therapies to integral options within advanced heart failure care pathways, driven by improvements in durability, biocompatibility, and implantation techniques. Contemporary device architectures emphasize reduced thrombogenicity, smaller form factors, and energy efficiency, which together have expanded candidacy among older and more comorbid patients. Simultaneously, refined surgical approaches and percutaneous-adjunct strategies have lowered perioperative risk, thereby enabling wider institutional adoption across tertiary and specialized centers.

Moreover, shifting clinical paradigms have blurred traditional boundaries between temporary and long-term mechanical circulatory support, prompting clinicians to consider device therapy earlier in the disease course for select patient cohorts. Payers and health systems are increasingly focused on value-based outcomes and readmission reduction, which elevates the importance of longitudinal device performance and comprehensive peri-implant care programs. As a result, manufacturers, clinicians, and hospitals are coalescing around evidence-generation and real-world data initiatives to quantify quality-of-life improvements and long-term survival benefits.

In parallel, regulatory frameworks continue to evolve to balance timely patient access with robust post-market surveillance, encouraging iterative device enhancements while maintaining patient safety. Taken together, these dynamics have created a complex but fertile environment for innovation, partnership, and strategic differentiation across the ecosystem supporting ventricular assist device therapy.

Identifying the transformative shifts reshaping clinical practice, technology development, and commercial models in mechanical circulatory support

Several convergent shifts are redefining how ventricular assist devices are developed, evaluated, and deployed. First, engineering advances in continuous flow designs, including axial and centrifugal platforms, have enhanced hemodynamic efficiency and durability, which in turn influence surgical selection and long-term management. Second, integration of digital telemetry and remote monitoring capabilities is enabling proactive management of device performance and patient status, thus shortening feedback loops between outpatient clinicians and implant teams.

Concurrently, clinical evidence is expanding indications beyond classic bridge-to-transplant scenarios toward bridge-to-recovery and destination therapy for select populations, prompting multidisciplinary teams to reassess candidacy criteria. The rise of patient-centered outcomes has shifted evaluation metrics to include functional status and quality of life, not solely survival, which affects reimbursement conversations and clinical adoption. Furthermore, manufacturing and supply chain strategies are evolving as companies pursue vertical integration, production scalability, and regulatory harmonization across jurisdictions to reduce time to market for iterative device updates.

Finally, strategic collaborations among device manufacturers, academic centers, and health systems are accelerating translational research and real-world evidence generation. These partnerships are fostering adaptive clinical trial designs and registries that better capture long-term device performance and complications, thereby informing iterative improvements in patient selection, perioperative protocols, and post-implant care.

Examining the cumulative implications of recent and anticipated United States tariff policy changes for the ventricular assist device value chain and procurement strategies

Tariff adjustments implemented in 2025 have introduced complexity across the ventricular assist device supply chain, affecting components, finished systems, and ancillary disposables. These policy changes have increased procurement scrutiny among hospital purchasing teams and device manufacturers, prompting reassessments of sourcing strategies, supplier diversification, and inventory management. In response, some manufacturers have accelerated localization of critical component production and engaged contract manufacturers to mitigate exposure to trade-related price volatility.

Healthcare providers have reacted by enhancing procurement governance and exploring longer-term supply agreements to provide price stability and continuity of care. At the same time, smaller suppliers and niche component vendors have experienced differential impacts, leading to potential consolidation as organizations seek scale to absorb tariff-related cost pressures. Importantly, clinical teams are monitoring any indirect effects on device availability and service parts, because even modest disruptions can influence scheduled implant programs and post-implant support.

Policy uncertainty has also elevated the role of total cost of care analyses in procurement decisions, with hospital systems demanding greater transparency around landed costs, warranty terms, and service network reliability. As a result, manufacturers that proactively adapt their commercial models to offer bundled service agreements, improved lead-time assurances, and localized support are positioned to maintain competitive advantage under the revised tariff environment.

Interpreting segmentation dynamics across flow architecture, device type, clinical indication, product configuration, and care setting to reveal strategic opportunities and clinical intersections

Flow architecture distinctions between continuous flow systems and pulsatile platforms continue to shape clinical practice, with continuous flow devices-particularly axial and centrifugal configurations-favored for their reliability and smaller profiles, whereas pulsatile technologies retain a defined niche where physiologic pulsatility is clinically prioritized. Device type segmentation into left, right, and biventricular systems underscores how therapeutic intent drives technological design; left ventricular support remains the most commonly deployed modality for chronic support, while right and biventricular solutions play critical roles in acute decompensation and complex perioperative cases.

Indication-based differentiation across bridge-to-recovery, bridge-to-transplant, and destination therapy informs not only clinical decision-making but also programmatic design within health systems, as each indication demands distinct pre-implant evaluation, follow-up care pathways, and psychosocial support models. Product-level choices between external and implantable systems further interact with patient lifestyle considerations, infection risk management, and long-term device maintenance strategies. Finally, end-user segmentation that includes ambulatory surgical centers alongside hospitals highlights evolving care-delivery models, with ambulatory settings increasingly managing select perioperative workflows while hospitals retain responsibility for complex implants and long-term management.

Together, these segmentation axes intersect to create nuanced adoption patterns and service needs, suggesting that manufacturers and providers who align product development, clinical support, and training programs to these differentiated requirements will be better positioned to address clinician preferences and patient expectations.

Regional distinctions in regulatory frameworks, payer dynamics, and clinical adoption that shape commercialization and evidence-generation strategies across global territories

The Americas region features advanced tertiary care networks, a high concentration of specialized implant centers, and regulatory pathways that emphasize robust clinical evidence and post-market surveillance; these conditions support the adoption of advanced implantable technologies and complex care programs. In contrast, Europe, Middle East & Africa presents a heterogeneous landscape where reimbursement mechanisms, national health authority processes, and hospital procurement models vary significantly, driving the need for flexible commercialization strategies and region-specific clinical engagement. Meanwhile, Asia-Pacific encompasses rapidly developing health infrastructure in certain markets alongside highly advanced centers of excellence in others, creating a dual focus on cost-effective solutions and cutting-edge innovation adoption.

Across these regions, local clinical practice patterns, surgeon experience, and the density of specialized heart failure programs influence how quickly new device architectures are integrated into treatment algorithms. Furthermore, regulatory harmonization efforts and regional initiatives to strengthen post-market data collection are beginning to reduce barriers to multi-jurisdictional evidence generation, although implementation timelines remain uneven. As a result, companies pursuing global expansion must tailor clinical education, service networks, and reimbursement strategies to accommodate diverse payer expectations and healthcare delivery models while leveraging regional centers of excellence to accelerate clinician adoption and build robust real-world evidence.

Competitive dynamics and partnership strategies that emphasize platform innovation, service integration, and evidence-led differentiation across the device ecosystem

Industry participants have pursued divergent strategies to differentiate offerings: some prioritize incremental device refinements to improve hemocompatibility and battery efficiency, while others emphasize platform initiatives that integrate remote monitoring and predictive analytics. Strategic partnerships between device developers and academic institutions have accelerated translational research and clinical validation, enabling faster cycles of iterative improvement. In addition, vertical integration of service networks and the expansion of in-house technical support teams have emerged as critical differentiators for companies seeking to secure long-term hospital relationships and ensure high uptime for implanted devices.

Mergers and acquisitions remain a pathway for acquiring complementary technologies, bolstering service capabilities, and expanding geographic reach, particularly where companies seek to plug gaps in product lines or augment post-market surveillance infrastructure. At the same time, newer entrants and specialized component suppliers are challenging incumbents by offering niche innovations in areas such as driveline infection mitigation, sensor integration, and hemodynamic optimization algorithms. Collectively, these competitive dynamics prioritize not only device performance but also the quality of clinical training, clarity of warranty and service commitments, and the depth of evidence supporting long-term patient outcomes.

Actionable strategic priorities for manufacturers and providers to reinforce supply resilience, evidence generation, and value-driven commercial models in device therapy

First, prioritize investment in post-market data collection and remote monitoring infrastructure to demonstrate real-world device performance and drive earlier clinical acceptance. Aligning evidence-generation efforts with payer requirements and clinician priorities will facilitate reimbursement discussions and support broader adoption. Second, strengthen supply chain resilience by diversifying suppliers of critical components and by exploring localized manufacturing partnerships where feasible to reduce exposure to trade-related disruption and lead-time variability. Third, develop bundled commercial offerings that combine device hardware, warranty coverage, and predictable service agreements to simplify procurement and reduce operational risk for hospital systems.

Moreover, expand clinician education programs that incorporate simulation, proctorship, and multidisciplinary care-team training to minimize perioperative complications and optimize patient selection. Leverage regional centers of excellence to accelerate peer-to-peer knowledge transfer and to generate high-quality real-world evidence. Finally, adopt a patient-centered product development mindset that emphasizes quality of life, ease of use, and long-term care coordination, because these factors increasingly drive device preference among clinicians and patients alike. By implementing these recommendations in concert, leaders can strengthen competitive positioning while improving clinical outcomes and operational reliability.

A rigorous mixed-methods research approach integrating primary clinical interviews, secondary evidence synthesis, and stakeholder validation for reliable insights

The research approach integrates qualitative and quantitative methods to produce a comprehensive view of clinical practice, technology trends, and commercial dynamics. Primary data collection involves structured interviews with clinicians, clinical engineers, procurement leaders, and regulatory specialists to capture frontline perspectives on device performance, service expectations, and adoption barriers. Secondary literature synthesis draws on peer-reviewed clinical studies, guideline statements, regulatory communications, and technical white papers to contextualize primary findings and to verify clinical assertions.

In addition, structured stakeholder validation sessions were used to reconcile divergent viewpoints, test hypotheses emerging from the analysis, and refine recommendations. Where appropriate, device technical specifications, bench-test reports, and post-market surveillance summaries were cross-referenced to corroborate claims about device architecture and clinical application. Throughout, methodological rigor was maintained by applying transparent inclusion criteria for sources, documenting interview protocols, and employing iterative triangulation to enhance reliability. This mixed-methods design ensures that the insights are both clinically grounded and operationally relevant for decision-makers.

A concise synthesis linking technological advancement, clinical practice evolution, and strategic imperatives for sustainable progress in mechanical circulatory support

In synthesis, the ventricular assist device field is at an inflection point where engineering advances, evolving clinical indications, and shifting commercial realities converge to create new opportunities and challenges. Device improvements in flow technology, miniaturization, and digital integration are enabling broader patient access and more refined care pathways, while tariff-related supply-chain pressures and regional variability in regulation and reimbursement require adaptive commercial and operational strategies. Consequently, successful organizations will be those that combine technical excellence with robust evidence-generation, resilient supply networks, and comprehensive clinician and patient support programs.

Looking ahead, coordinated efforts among manufacturers, clinical leaders, and health systems to prioritize real-world data collection, streamline procurement models, and enhance training will be essential to translate technological promise into sustained clinical benefit. By focusing on these integrated priorities, stakeholders can improve patient outcomes, reduce system-level risks, and position device therapy as a durable, patient-centered option within advanced heart failure care paradigms.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of fully implantable left ventricular assist devices with wireless transcutaneous energy transmission systems
  • 5.2. Integration of machine learning algorithms for predictive monitoring and early warning of ventricular assist device complications
  • 5.3. Development of magnetically levitated pump technology to reduce hemolysis and device-related thrombosis in VAD patients
  • 5.4. Expansion of destination therapy indications driving demand for long-term durable ventricular assist device support
  • 5.5. Clinical trials assessing biocompatible surface coatings to minimize immune response and infection risks in VAD implants
  • 5.6. Growth of pediatric ventricular assist device programs fueled by miniaturized continuous flow pump designs for children
  • 5.7. Regulatory approvals and reimbursement policies shaping accessibility of next-generation implantable assist devices
  • 5.8. Emergence of remote patient monitoring platforms for real-time data transmission from implanted ventricular assist devices

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ventricular Assist Device Market, by Flow Class

  • 8.1. Continuous Flow
    • 8.1.1. Axial Flow
    • 8.1.2. Centrifugal Flow
  • 8.2. Pulsatile Flow

9. Ventricular Assist Device Market, by Device Type

  • 9.1. Biventricular
  • 9.2. Left
  • 9.3. Right

10. Ventricular Assist Device Market, by Indication

  • 10.1. Bridge To Recovery
  • 10.2. Bridge To Transplant
  • 10.3. Destination Therapy

11. Ventricular Assist Device Market, by Product

  • 11.1. External
  • 11.2. Implantable

12. Ventricular Assist Device Market, by End-User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. Ventricular Assist Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ventricular Assist Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ventricular Assist Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. Medtronic plc
    • 16.3.3. Abiomed, Inc.
    • 16.3.4. LivaNova PLC
    • 16.3.5. Berlin Heart GmbH
    • 16.3.6. Jarvik Heart, Inc.
    • 16.3.7. CARMAT SA
    • 16.3.8. CorWave SAS
    • 16.3.9. Terumo Corporation
    • 16.3.10. SynCardia Systems, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. VENTRICULAR ASSIST DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. VENTRICULAR ASSIST DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VENTRICULAR ASSIST DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVENTRICULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVENTRICULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVENTRICULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVENTRICULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVENTRICULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVENTRICULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LEFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LEFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LEFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LEFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LEFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LEFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RIGHT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RIGHT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RIGHT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RIGHT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RIGHT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RIGHT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY EXTERNAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY IMPLANTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY IMPLANTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY IMPLANTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY IMPLANTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY IMPLANTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 142. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 182. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 184. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 191. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 192. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 196. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 197. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 198. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 220. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 221. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 222. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 226. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 227. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 228. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 231. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 234. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 235. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 236. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 237. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 240. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 241. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 242. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 243. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 244. GCC VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 259. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 262. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 263. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 264. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 265. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 268. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 269. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 270. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 271. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 272. BRICS VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 273. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 276. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 277. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 278. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 279. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 282. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 283. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 284. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 285. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 286. G7 VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 287. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 290. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 291. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 292. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 293. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 296. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 297. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 298. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 299. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 300. NATO VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 305. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 307. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 310. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 311. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 312. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 313. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 314. UNITED STATES VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 315. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2018-2024 (USD MILLION)
  • TABLE 316. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW CLASS, 2025-2032 (USD MILLION)
  • TABLE 317. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 318. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 319. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 322. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 323. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 324. CANADA VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PRODUCT, 2025-2